Variations and obstacles in the use of coagulation factor concentrates for major trauma bleeding across Europe: outcomes from a European expert meeting

PURPOSE: Trauma is a leading cause of mortality, with major bleeding and trauma-induced coagulopathy (TIC) contributing to negative patient outcomes. Treatments for TIC include tranexamic acid (TXA), fresh frozen plasma (FFP), and coagulation factor concentrates (CFCs, e.g. prothrombin complex conce...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Trauma Emerg Surg
Autori principali: Černý, Vladimir, Maegele, Marc, Agostini, Vanessa, Fries, Dietmar, Leal-Noval, Santiago R., Nardai, Gábor, Nardi, Giuseppe, Östlund, Anders, Schöchl, Herbert
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2021
Soggetti:
Review Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7782571/
https://ncbi.nlm.nih.gov/pubmed/33399876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00068-020-01563-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi